| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -9.8e-05 | 1 |